Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)

NCT07224347 is registered in ClinicalTrials.gov with Anne Murray as lead sponsor.

NCT NCT07224347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07224347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)
Lead sponsor
Anne Murray
Phase
Observational
Overall status
Active, not recruiting
Start date
July 15, 2019
Completion date
April 30, 2026
Enrollment
19,114 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, cancer, dementia, depression, frailty, functional disability, heart disease, stroke